Get Demo
1 min read

Oncology: Hepatitis B Serology Testing and Prophylactic Treatment Prior to Receiving Anti-CD20 Targeting Drugs

Percentage of patients tested for Hepatitis B prior to receiving anti-CD20 targeting treatment, including rituximab, ofatumumab, and obinutuzumab; patients testing positive for Hepatitis B receive prophylactic treatment.
admin_macra

admin_macra

Administrator

Published

May 22, 2026

Reading Time

1 min read

Percentage of patients tested for Hepatitis B prior to receiving anti-CD20 targeting treatment, including rituximab, ofatumumab, and obinutuzumab; patients testing positive for Hepatitis B receive prophylactic treatment.

  • TRENDING ANALYTICS

Engineering

Optimizing Vector Databases for RAG Applications

Engineering

The ROI of Migrating to a Semantic Layer

Engineering

The ROI of Migrating to a Semantic Layer

READING PROGRESS

SHARE ARTICLE